Harleysville, PA, United States of America

Anthony S Bean



 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Lansdale, PA (US) (2012)
  • Harleysville, PA (US) (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anthony S Bean

Introduction

Anthony S Bean is a notable inventor based in Harleysville, PA (US). He has made significant contributions to the field of pharmaceuticals, holding 2 patents that showcase his innovative spirit and technical expertise. His work primarily focuses on improving drug formulations and stability.

Latest Patents

One of his latest patents is for rapidly disintegrating coated tablets. This invention involves coated dosage forms comprising a tablet core, preferably in compressed form, that has a coating over its exterior surface and one or more patterns debossed in the tablet surface. The patent also discloses methods for manufacturing such dosage forms. Another significant patent by Bean relates to a method for stabilizing phenylephrine. This process includes drying an acidic solution of phenylephrine and developing pharmaceutical compositions that include stabilized phenylephrine.

Career Highlights

Throughout his career, Anthony S Bean has worked with prominent companies such as McNeil-PPC, Inc. and Johnson & Johnson Consumer Inc. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in pharmaceutical technology.

Collaborations

Bean has collaborated with talented individuals in his field, including Hugh Huang and Jonathan Zeszotarski. These partnerships have likely enriched his work and led to further innovations in drug formulation and stability.

Conclusion

Anthony S Bean's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of effective and stable drug formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…